-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a batch of chain pharmacies came to the news of cancellation
.
Shanxi Province Food and Drug Administration recently issued a circular that apply for cancellation of "drug business license," according to the Shanxi 9 Kang large pharmacy chain Limited, in accordance with relevant regulations, decided to cancel Shanxi 9 Kang large pharmacy chain Limited "Drug License"
.
Not long ago, the Liaoning Provincial Food and Drug Administration also cancelled the "Pharmaceutical Business License" of Chaoyang Huaxing Pharmacy Chain Co.
, Ltd.
upon application
.
According to incomplete statistics, since this year, Ningxia, Inner Mongolia, Yunnan and other places have issued announcements on the cancellation of chain pharmacies.
Many of them have headquarters.
For example, on May 6 this year, Yunnan Provincial Food and Drug Administration cancelled Yunnan Jianjun Pharmaceutical according to law.
Pharmaceutical Industry Co.
, Ltd.
’s "Pharmaceutical Business License"
.
It is understood that Yunnan Jianjun Pharmaceutical is the headquarters of a local chain drugstore in Baoshan City.
The chain has a history of 18 years and all its 21 branches have been cancelled
.
Behind the closure of these chain pharmacies one after another, it revealed a big signal-industry competition is intensifying
.
According to data from the National Food and Drug Administration, as of the end of March 2021, the total number of pharmacies nationwide reached 561,000, of which 241,900 were monomer pharmacies and 319,100 were chain stores; as of the end of June 2021, there were a total of " There are 598,900 companies holding the "Pharmaceutical Business License"
.
Among them, there are 6,619 retail chain headquarters, 329,600 retail chain stores, and 249,400 single drug stores
.
Compared with the data in March, although the number has increased, the industry pointed out that from the overall environment, the supply of domestic pharmacies exceeds demand, and competition is expected to intensify
.
On October 28, 2021, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-quality Development of the Pharmaceutical Circulation Industry during the "14th Five-Year Plan" Period", which clearly put forward the requirements for increasing the concentration of the industry
.
Among them, it is mentioned that by 2025, 5-10 specialized and diversified pharmaceutical retail chain enterprises with a value of over 50 billion yuan will be cultivated.
The annual sales of the top 100 pharmaceutical retail companies account for more than 65% of the total pharmaceutical retail market.
The chain rate is close to 70%
.
According to statistics from the State Drug Administration, as of the end of March 2021, the chain rate of pharmacies nationwide was 56.
88%
.
Compared with the end of 2020, the total number of stores in three months has increased by 1.
26%, and the chain rate has increased by 0.
67%
.
Now that the development goal of “retail chaining rate close to 70%” is to be completed in 2025, industry mergers and acquisitions may intensify
.
Faced with the huge pressure of transformation and upgrading caused by the increase in industry concentration, the reshuffle of the pharmaceutical industry has been further accelerated
.
Among them, the major chain giants are accelerating the race to enclose their land and continuously increasing the chain rate
.
As of the third quarter of 2021, the number of stores in the four major listed chains of Yixintang, Dashenlin, Laobaixing, and Yifeng Pharmacy has exceeded 7,000, and the number of Yixintang and Laobaixing stores has reached more than 8,000, while Yifeng Pharmacy and Yifeng Pharmacy The total number of Dashenlin stores is more than 7,000
.
The industry pointed out that in the context of market reshuffle, small and medium-sized chain pharmacies are facing greater challenges in their survival.
If they want to develop and expand, they must either take a specialized route to become stronger and bigger, or be acquired
.
At present, some small and medium chains that do not want to be acquired are also accelerating their layout
.
For example, since 2021, chain pharmacies such as Dingdang Kuaiyao, Quanyuantang, Chinese Health, Supai Health, Yuanxin Technology, and Dajia Weikang have all publicized prospectuses and IPOs are on the agenda
.
The industry speculates that these pharmacies may use the wave of listing and then break through, so as to withstand the impact of the turmoil in the pharmaceutical industry
.
.
Shanxi Province Food and Drug Administration recently issued a circular that apply for cancellation of "drug business license," according to the Shanxi 9 Kang large pharmacy chain Limited, in accordance with relevant regulations, decided to cancel Shanxi 9 Kang large pharmacy chain Limited "Drug License"
.
Not long ago, the Liaoning Provincial Food and Drug Administration also cancelled the "Pharmaceutical Business License" of Chaoyang Huaxing Pharmacy Chain Co.
, Ltd.
upon application
.
According to incomplete statistics, since this year, Ningxia, Inner Mongolia, Yunnan and other places have issued announcements on the cancellation of chain pharmacies.
Many of them have headquarters.
For example, on May 6 this year, Yunnan Provincial Food and Drug Administration cancelled Yunnan Jianjun Pharmaceutical according to law.
Pharmaceutical Industry Co.
, Ltd.
’s "Pharmaceutical Business License"
.
It is understood that Yunnan Jianjun Pharmaceutical is the headquarters of a local chain drugstore in Baoshan City.
The chain has a history of 18 years and all its 21 branches have been cancelled
.
Behind the closure of these chain pharmacies one after another, it revealed a big signal-industry competition is intensifying
.
According to data from the National Food and Drug Administration, as of the end of March 2021, the total number of pharmacies nationwide reached 561,000, of which 241,900 were monomer pharmacies and 319,100 were chain stores; as of the end of June 2021, there were a total of " There are 598,900 companies holding the "Pharmaceutical Business License"
.
Among them, there are 6,619 retail chain headquarters, 329,600 retail chain stores, and 249,400 single drug stores
.
Compared with the data in March, although the number has increased, the industry pointed out that from the overall environment, the supply of domestic pharmacies exceeds demand, and competition is expected to intensify
.
On October 28, 2021, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-quality Development of the Pharmaceutical Circulation Industry during the "14th Five-Year Plan" Period", which clearly put forward the requirements for increasing the concentration of the industry
.
Among them, it is mentioned that by 2025, 5-10 specialized and diversified pharmaceutical retail chain enterprises with a value of over 50 billion yuan will be cultivated.
The annual sales of the top 100 pharmaceutical retail companies account for more than 65% of the total pharmaceutical retail market.
The chain rate is close to 70%
.
According to statistics from the State Drug Administration, as of the end of March 2021, the chain rate of pharmacies nationwide was 56.
88%
.
Compared with the end of 2020, the total number of stores in three months has increased by 1.
26%, and the chain rate has increased by 0.
67%
.
Now that the development goal of “retail chaining rate close to 70%” is to be completed in 2025, industry mergers and acquisitions may intensify
.
Faced with the huge pressure of transformation and upgrading caused by the increase in industry concentration, the reshuffle of the pharmaceutical industry has been further accelerated
.
Among them, the major chain giants are accelerating the race to enclose their land and continuously increasing the chain rate
.
As of the third quarter of 2021, the number of stores in the four major listed chains of Yixintang, Dashenlin, Laobaixing, and Yifeng Pharmacy has exceeded 7,000, and the number of Yixintang and Laobaixing stores has reached more than 8,000, while Yifeng Pharmacy and Yifeng Pharmacy The total number of Dashenlin stores is more than 7,000
.
The industry pointed out that in the context of market reshuffle, small and medium-sized chain pharmacies are facing greater challenges in their survival.
If they want to develop and expand, they must either take a specialized route to become stronger and bigger, or be acquired
.
At present, some small and medium chains that do not want to be acquired are also accelerating their layout
.
For example, since 2021, chain pharmacies such as Dingdang Kuaiyao, Quanyuantang, Chinese Health, Supai Health, Yuanxin Technology, and Dajia Weikang have all publicized prospectuses and IPOs are on the agenda
.
The industry speculates that these pharmacies may use the wave of listing and then break through, so as to withstand the impact of the turmoil in the pharmaceutical industry
.
